← Back to Clinical Trials
Recruiting NCT06849076

NCT06849076 The Influence of Talocrural Manipulation on Proprioception in Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06849076
Status Recruiting
Phase
Sponsor Bitlis Eren University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 26 participants
Start Date 2025-04-14
Primary Completion 2026-11-01

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Placebo Talocrural Joint ManipulationTalocrural Joint Manipulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 26 participants in total. It began in 2025-04-14 with a primary completion date of 2026-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to investigate the effect of talocrural joint manipulation on the ankle proprioception of patients with stroke.

Eligibility Criteria

Inclusion Criteria: 1. Two months or longer elapsed since the stroke, 2. A Mini-Mental State Examination score of 24 or higher, 3. Being between 45 and 75 years of age, 4. Having a Brunnstrom stage of 4 or above Exclusion Criteria: 1. The presence of severe osteoarthritis in the lower extremity, 2. The presence of cancer or diabetic neuropathy, 3. The presence of vestibular disorder, 4. The presence of lower extremity ulceration or amputation, 5. Hemodynamic instability, 6. The presence of other neurological disorders (such as multiple sclerosis, Parkinson's disease), 7. Having experienced an acute lower extremity injury in the last six weeks, 8. History of lower extremity surgery 9. Lack of available range of motion values required for the ankle proprioception test

Contact & Investigator

Central Contact

ömer dursun, Asst. Prof.

✉ fztomrdrsn@gmail.com

📞 5426088687

Principal Investigator

ömer dursun, Asst. Prof.

PRINCIPAL INVESTIGATOR

Bitlis Eren University

Frequently Asked Questions

Who can join the NCT06849076 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 75 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06849076 currently recruiting?

Yes, NCT06849076 is actively recruiting participants. Contact the research team at fztomrdrsn@gmail.com for enrollment information.

Where is the NCT06849076 trial being conducted?

This trial is being conducted at Bolu, Turkey (Türkiye).

Who is sponsoring the NCT06849076 clinical trial?

NCT06849076 is sponsored by Bitlis Eren University. The principal investigator is ömer dursun, Asst. Prof. at Bitlis Eren University. The trial plans to enroll 26 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology